wedge
Myocardial Infarction Animal Models & CRO Services
Myocardial Infarction Animal Models & CRO Services BIOTROFIX - Premier Preclinical CRO - Stroke, Alzheimer's, ALS, TBI Research - Seth P. Finklestein, M.D., CEO Myocardial Infarction Animal Models & CRO Services Myocardial Infarction Animal Models & CRO Services - Preclinical Cardiac Disease
Myocardial Infarction Animal Models & CRO Services Myocardial Infarction Animal Models & CRO Services Myocardial Infarction Animal Models & CRO Services Myocardial Infarction Animal Models & CRO Services Myocardial Infarction Animal Models & CRO Services
 
Home
greybar
The Company
greybar
Preclinical Drug Development
greybar
Preclinical Research Services
PK/PD Studies

Acute Stroke

Stroke Recovery

Intracerebral Hemorrhage

Alzheimer's Disease

Amyotrophic Lateral Sclerosis

Traumatic Brain Injury

Spinal Cord Injury

Muscular Dystrophy

Myocardial Infarction

Peripheral Vascular Disease

Others

Will Travel Services
greybar
The Team
greybar
News from Biotrofix
greybar
Publications
greybar
Contact Us


Well-equipped CRO laboratory
 

Myocardial Infarction Animal Models & CRO Services

Heart Attack - Myocardial Infarction Animal Models & CRO Services - Preclinical Cardiac DiseaseCardiac disease is a major cause of death and disability in the U.S. and worldwide. This is often due to atherosclerosis ("hardening of the arteries") and occlusion of the coronary arteries, leading to myocardial infarction (MI, "heart attack") and its late complications. About 1 million Americans suffer an acute MI each year, accounting for 180,000 deaths. About 5.8 million Americans have chronic congestive heart failure (CHF), most often due to ischemic heart disease and previous MIs.

Biotrofix is highly-experienced in rodent models of myocardial infarction (MI). In these models, the left coronary artery (LCA) is surgically ligated, resulting in low blood flow (ischemia) and death of cardiac tissue supplied by that artery. MI volume is assessed by histological methods. Both permanent and temporary (ischemia/reperfusion) MI models are available. Models of CHF in animals with chronic MI are also available. These models are appropriate for preclinical testing of agents useful for the treatment of MI and chronic CHF.


Contact Biotrofic for Myocardial Infarction Research and Studies

 

 
 
Home | The Company | Preclinical Research Services | The Team | News | Publications | Contact Us | Site Map
wedgeBiotrofix, Inc. 55 Union Street, Worcester, MA 01608 Tel: 781-314-9300 Fax: 781-465-6061


Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.